The Cooper Companies Inc
(BSP:C1OO34)
R$
60.54
0 (0%)
Market Cap: 120.57 Bil
Enterprise Value: 135.18 Bil
PE Ratio: 58.61
PB Ratio: 2.64
GF Score: 81/100 Cooper Companies Inc at Wells Fargo Healthcare Conference Transcript
Sep 06, 2023 / 07:00PM GMT
Release Date Price:
R$45.58
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
All right. Good afternoon, everyone. I'm Larry Biegelsen, the medical device analyst at Wells Fargo. It's my pleasure to host this session with the management from the CooperCompanies.
With us, we have Al White, President and CEO; Kim Duncan, Vice President of IR and Risk Management. In terms of format, it's going to be a fireside chat. If you have a question, please raise your hand. We'll come around with the mic. So Al and Kim, thanks so much for being here.
Albert G. White
CooperCompanies - President, CEO & Non-Independent Director
Yes. Thanks, Larry.
Questions & Answers
Lawrence H. Biegelsen
Wells Fargo Securities, LLC, Research Division - Senior Medical Device Equity Research Analyst
So Al, let's start with a recap of the Q3 results. Very strong organic growth of 12%, but EPS only beat consensus, I think, by $0.01 despite the top line beat of about $30 million. So talk
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot